Why it is time to prioritize the sustainable development of AI
artificial intelligence in chemistry and drug design :: Article Creator Artificial Intelligence-Driven Drug Design (AIDD) In Cancer Therapeutics Cancer continues to be a substantial global health issue. By customizing prevention, diagnosis, and treatment plans depending on individual patient genetic makeup, environment, and lifestyle, precision medicine presents a hopeful path. PM allows tailored treatment plans meant to increase patient outcomes by combining multi-omics and multi-modal data. In this field artificial intelligence (AI), especially machine learning (ML) and deep learning, has become a rather effective instrument. By using big data and artificial intelligence, complex datasets including genomics, transcriptomics, proteomics, radiomics, and digital pathology can have meaningful insights extracted and hidden trends can be found. These technologies support the identification of new biomarkers for cancer screening, diagnosis, therapy choic...